142 related articles for article (PubMed ID: 35082928)
1. Associations of Genetic Polymorphisms of mTOR rs2295080 T/G and rs1883965 G/A with Susceptibility of Urinary System Cancers.
Min Z; Mi Y; Lv Z; Sun Y; Tang B; Wu H; Zhang Z; Pan H; Zhang Y; Lu C; Zuo L; Zhang L
Dis Markers; 2022; 2022():1720851. PubMed ID: 35082928
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of mTOR and cancer risk: a systematic review and updated meta-analysis.
Zining J; Lu X; Caiyun H; Yuan Y
Oncotarget; 2016 Aug; 7(35):57464-57480. PubMed ID: 27462867
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of the effect of rs2295080 and rs2536 polymorphisms within the mTOR gene on cancer risk.
Qi GH; Wang CH; Zhang HG; Yu JG; Ding F; Song ZC; Xia QH
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32597485
[TBL] [Abstract][Full Text] [Related]
4. A polymorphism (rs2295080) in mTOR promoter region and its association with gastric cancer in a Chinese population.
Xu M; Tao G; Kang M; Gao Y; Zhu H; Gong W; Wang M; Wu D; Zhang Z; Zhao Q
PLoS One; 2013; 8(3):e60080. PubMed ID: 23555892
[TBL] [Abstract][Full Text] [Related]
5. Functional promoter rs2295080 T>G variant in MTOR gene is associated with risk of colorectal cancer in a Chinese population.
Xu M; Gao Y; Yu T; Wang J; Cheng L; Cheng L; Cheng D; Zhu B
Biomed Pharmacother; 2015 Mar; 70():28-32. PubMed ID: 25776475
[TBL] [Abstract][Full Text] [Related]
6. Impacts of the mTOR gene polymorphisms rs2536 and rs2295080 on breast cancer risk in the Chinese population.
Zhao Y; Diao Y; Wang X; Lin S; Wang M; Kang H; Yang P; Dai C; Liu X; Liu K; Li S; Zhu Y; Dai Z
Oncotarget; 2016 Sep; 7(36):58174-58180. PubMed ID: 27533457
[TBL] [Abstract][Full Text] [Related]
7. Associations of genetic polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer risk: A meta-analysis in Asian population.
Zhang Z; Chen Q; Zhang J; Wang Y; Hu X; Yin S; He M; Guan S; Qin W; Xiao Q; Zhao H; Yao W; Wu H; Wei M
Sci Rep; 2017 Dec; 7(1):17844. PubMed ID: 29259266
[TBL] [Abstract][Full Text] [Related]
8. MTOR gene polymorphism may be associated with microscopic polyangiitis susceptibility in a Guangxi population of China.
Lan J; Zhu Y; Rao J; Liu L; Gong A; Feng F; Chen B; Huang J; Zhang Y; Chu L; Zhong H; Li L; Yan J; Li W; Xue C
Gene; 2023 Feb; 854():147101. PubMed ID: 36496178
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the mTOR gene and risk of sporadic prostate cancer in an Eastern Chinese population.
Li Q; Gu C; Zhu Y; Wang M; Yang Y; Wang J; Jin L; Zhu ML; Shi TY; He J; Zhou X; Ye DW; Wei Q
PLoS One; 2013; 8(8):e71968. PubMed ID: 23940798
[TBL] [Abstract][Full Text] [Related]
10. Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population.
Chen J; Shao P; Cao Q; Li P; Li J; Cai H; Zhu J; Wang M; Zhang Z; Qin C; Yin C
PLoS One; 2012; 7(7):e40817. PubMed ID: 22815832
[TBL] [Abstract][Full Text] [Related]
11. The possible effects of the MTOR polymorphisms on preeclampsia susceptibility, severity, and onset: a case-control study and in silico analysis.
Rezaei M; Ghasemi M; Saravani M; Ghahghayi F; Shahraki-Ghadim H; Salimi S
Mol Biol Rep; 2024 Feb; 51(1):335. PubMed ID: 38393518
[TBL] [Abstract][Full Text] [Related]
12. [Association of mammalian target of rapamycin gene polymorphisms with the risk of pediatric epilepsy].
Yue X; Zhao PW; Liu ZS; Wu GF; Tu F; Hu JS; He XL
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):560-4. PubMed ID: 26108313
[TBL] [Abstract][Full Text] [Related]
13. A functional variant in the MTOR promoter modulates its expression and is associated with renal cell cancer risk.
Cao Q; Ju X; Li P; Meng X; Shao P; Cai H; Wang M; Zhang Z; Qin C; Yin C
PLoS One; 2012; 7(11):e50302. PubMed ID: 23209702
[TBL] [Abstract][Full Text] [Related]
14. Association of mTOR polymorphisms with cancer risk and clinical outcomes: a meta-analysis.
Shao J; Li Y; Zhao P; Yue X; Jiang J; Liang X; He X
PLoS One; 2014; 9(5):e97085. PubMed ID: 24816861
[TBL] [Abstract][Full Text] [Related]
15. Autophagy Genes for Wet Age-Related Macular Degeneration in a Finnish Case-Control Study.
Paterno JJ; Koskela A; Hyttinen JMT; Vattulainen E; Synowiec E; Tuuminen R; Watala C; Blasiak J; Kaarniranta K
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33172148
[TBL] [Abstract][Full Text] [Related]
16. Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population.
He J; Wang MY; Qiu LX; Zhu ML; Shi TY; Zhou XY; Sun MH; Yang YJ; Wang JC; Jin L; Wang YN; Li J; Yu HP; Wei QY
Mol Carcinog; 2013 Nov; 52 Suppl 1():E70-9. PubMed ID: 23423739
[TBL] [Abstract][Full Text] [Related]
17. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development.
Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S
IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190
[TBL] [Abstract][Full Text] [Related]
18. mTOR pathway candidate genes and physical activity interaction on breast cancer risk in black women from the women's circle of health study.
Ilozumba MN; Yaghjyan L; Datta S; Zhao J; Gong Z; Hong CC; Lunetta KL; Zirpoli G; Bandera EV; Palmer JR; Yao S; Ambrosone CB; Cheng TD
Breast Cancer Res Treat; 2023 May; 199(1):137-146. PubMed ID: 36882608
[TBL] [Abstract][Full Text] [Related]
19. Effects of the mTOR and AKT genes polymorphisms on systemic lupus erythematosus risk.
Saravani M; Shahraki-Ghadimi H; Maruei-Milan R; Mehrabani M; Mirzamohammadi S; Nematollahi MH
Mol Biol Rep; 2020 May; 47(5):3551-3556. PubMed ID: 32319007
[TBL] [Abstract][Full Text] [Related]
20. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
Ding H; Dai Y; Ning Z; Fan N; Wang Z; Li P; Zhang L; Tao Y; Wang H
Medicine (Baltimore); 2016 Mar; 95(12):e2941. PubMed ID: 27015167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
